Affymetrix, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

AFFX 14.01
price chart
Origin Technologies Ups Affymetrix Bid to Topple Thermo Deal
Origin Technologies Corp. increased its all-cash offer to buy Affymetrix Inc. to $17 a share, as it seeks to top an agreed deal between the medical technology company and Thermo Fisher Scientific Inc. The new bid is 21 percent more than the $1.3 ...
Former Affymetrix Senior Executives Propose to Acquire Affymetrix for $16.10 ...  Business Wire (press release)
Are Analysts Bearish Affymetrix, Inc. (NASDAQ:AFFX) After Last Week?
Among 4 analysts covering Affymetrix (NASDAQ:AFFX), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Affymetrix had 7 analyst reports since August 27, 2015 according to SRatingsIntel.
Affymetrix, Inc. (AFFX) Shares Jump Nearly 50% After Acquisition by Thermo ...
This weekend, shares of Affymetrix, Inc. (NASDAQ:AFFX) are sitting pretty, at 49.84% higher than it's closing price on Friday.
Thermo Fisher to buy Affymetrix for $1.3 billion  Reuters
Affymetrix (AFFX) Stock Soars on $1.3 Billion Sale to Thermo Fisher Scientific  TheStreet.com
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against ...
3:16-cv-00921, on behalf of shareholders of Affymetrix, Inc. ("Affymetrix" or the "Company") (NasdaqGS: AFFX) who held Affymetrix securities on the record date, February 18, 2016, and have been harmed by Affymetrix's and its board of directors' (the ...
Affymetrix (AFFX) Determines Origin Technologies Bid Not a Superior Proposal  StreetInsider.com
Origin withdraws offer to buy Affymetrix  Reuters
Affymetrix to Engage in Discussions With Origin Technologies
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or the “Company”) today announced that the Company's Board of Directors has informed Origin Technologies Corporation, LLC (“Origin”) that the Company will engage ...
Thermo Fisher wages war of words as rival ups its bid for Affymetrix  Boston Business Journal (blog)
Enzo Reaches $10M Deal With Affymetrix To End Patent Row
Law360, New York (October 13, 2015, 6:05 PM EDT) -- Enzo Biochem Inc. has reached a $10 million settlement with Affymetrix Inc. to end an infringement suit alleging violation of a patent covering technology for nucleic acid analysis, Enzo announced on ...
Affymetrix and Athletigen Partner to Advance Genetics in Human Athletic ...
SANTA CLARA, Calif. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc., a direct-to-consumer sports genetics company, today announced a global partnership agreement.
Halifax startup Athletigen Technologies partners with California DNA ...  Cantech Letter
Affymetrix Reports Fourth Quarter 2015 Operating Results
On October 9, 2015, we entered into a settlement agreement with Enzo Life Sciences, Inc. ("Enzo") and agreed to pay $10.0 million with respect to the lawsuit filed by Enzo in April 2012.
Cancer Biomarker Market Key Players Abbott Laboratories, Agendia NV ...
Some of the noted companies in the global market are Abbott Laboratories, Agendia N.V, Affymetrix, Inc.(Acquired By Thermofisher), Agilent Technologies, Inc, Becton Dickinson And Company, Astellas Pharma Inc, Clarient, Inc. (Acquired By Neogenomics ...
Canaccord Genuity Reconfirms a “Buy” Rating on Autodesk (ADSK) and $120.0 ...
Among 21 analysts covering Autodesk Inc. (NASDAQ:ADSK), 13 have Buy rating, 2 Sell and 6 Hold. Therefore 62% are positive. Autodesk Inc. has $130 highest and $9 lowest target. $86.82's average target is -21.79% below currents $111.01 stock price.